Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Dec;32(12):1403-4.
doi: 10.1097/INF.0000000000000003.

Lower vancomycin serum trough concentrations might not be the answer

Affiliations
Comment

Lower vancomycin serum trough concentrations might not be the answer

Andrea Hahn et al. Pediatr Infect Dis J. 2013 Dec.
No abstract available

PubMed Disclaimer

Comment in

  • Reply: To PMID 23652479.
    Frymoyer A, Hersh AL. Frymoyer A, et al. Pediatr Infect Dis J. 2013 Dec;32(12):1404. doi: 10.1097/INF.0000000000000037. Pediatr Infect Dis J. 2013. PMID: 24569316 No abstract available.

Comment on

References

    1. Frymoyer A, Guglielmo BJ, Hersh AL. Desired Vancomycin Trough Serum Concentration for Treating Invasive Methicillin-Resistant Staphylococcal Infections. The Pediatric infectious disease journal. 2013 - PubMed
    1. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011;52:285–292. - PubMed
    1. Lamarre P, Lebel D, Ducharme MP. A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population. Antimicrobial agents and chemotherapy. 2000;44:278–282. - PMC - PubMed
    1. Jelliffe RW, Schumitzky A, Bayard D, et al. Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals. Clinical pharmacokinetics. 1998;34:57–77. - PubMed
    1. Kullar R, Davis SL, Levine DP, Rybak MJ. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011;52:975–981. - PubMed

MeSH terms